- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00279942
Effect of Revival Soy on Fibromyalgia Pain
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Fibromyalgia syndrome is a chronic, generalized pain syndrome that affects the musculoskeletal system (1). This syndrome is typically diagnosed in patients who experience generalized musculoskeletal pain and have excessive tenderness in at least 11 of 18 specific points (2). Although the primary cause of fibromyalgia syndrome is unclear, a growing body of evidence indicates that the widespread pain associated with this syndrome is due to abnormalities in the central nervous system. Therefore, drug therapy for fibromyalgia syndrome is most often aimed at the central nervous system and includes tricyclic antidepressants, selective serotonin reuptake inhibitors, dual serotonin and norepinephrine reuptake inhibitors, analgesics, and anticonvulsants (1).
In addition to medical therapies, complementary and alternative medicine therapies have been used to treat fibromyalgia syndrome symptoms (3). Soy is a widely used dietary supplement that has not been previously tested for treating fibromyalgia syndrome.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Women and men age 18 - 76
- Able to understand and sign a consent form
- Able to participate fully in all aspects of the study
- Currently participating in Mayo Clinic's Fibromyalgia Treatment Program
Exclusion Criteria:
- Pregnant or lactating women
- Allergy to soy or other study product ingredients
- Diagnosis of bipolar disorder, schizophrenia or dementia
- Diagnosis of diabetes mellitus or inflammatory bowel disease
- Presently on soy product or use of soy within the last 30 days
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Soy
A shake that contained 20 g of soy protein and 160 mg of soy isoflavone.
|
Drink a shake (vanilla and chocolate taste) once a day for 6 weeks.
Other Names:
|
PLACEBO_COMPARATOR: Placebo
A shake that contained 20 g of milk-based protein (casein) and no isoflavone.
|
Drink a shake (vanilla and chocolate taste) once a day for 6 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To gather preliminary data on whether dietary soy supplement can improve quality of life in patients with fibromyalgia as measured by the Fibromyalgia Impact Questionnaire (FIQ) and the Center for Epidemiologic Studies Depression Scale (CES-D).
Time Frame: 6 Weeks
|
6 Weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To assess the feasibility of recruiting 50 patients with fibromyalgia into a study of using a dietary supplement.
Time Frame: 3 Months
|
3 Months
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
General Publications
- Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA. 2004 Nov 17;292(19):2388-95. doi: 10.1001/jama.292.19.2388.
- Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990 Feb;33(2):160-72. doi: 10.1002/art.1780330203.
- Holdcraft LC, Assefi N, Buchwald D. Complementary and alternative medicine in fibromyalgia and related syndromes. Best Pract Res Clin Rheumatol. 2003 Aug;17(4):667-83. doi: 10.1016/s1521-6942(03)00037-8.
- Wahner-Roedler DL, Thompson JM, Luedtke CA, King SM, Cha SS, Elkin PL, Bruce BK, Townsend CO, Bergeson JR, Eickhoff AL, Loehrer LL, Sood A, Bauer BA. Dietary soy supplement on fibromyalgia symptoms: a randomized, double-blind, placebo-controlled, early phase trial. Evid Based Complement Alternat Med. 2011;2011:350697. doi: 10.1093/ecam/nen069. Epub 2011 Jun 23.
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2155-05
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibromyalgia
-
University of AberdeenCompletedFibromyalgia | Fibromyalgia, Primary | Fibromyalgia, SecondaryUnited Kingdom
-
Eli Lilly and CompanyCompletedFibromyalgia, Primary | Fibromyalgia, SecondaryMexico
-
Rasmia ElgoharyNot yet recruiting
-
Tel-Aviv Sourasky Medical CenterCompletedFibromyalgia (FM)Israel
-
Yousra Hisham Abdel FattahCompletedFibromyalgia, PrimaryEgypt
-
Forest LaboratoriesCypress Bioscience, Inc.TerminatedPrimary FibromyalgiaUnited States
-
Universidade Federal do Rio Grande do NorteCompleted
-
Tonix Pharmaceuticals, Inc.CompletedPrimary FibromyalgiaUnited States
-
Tonix Pharmaceuticals, Inc.CompletedPrimary FibromyalgiaUnited States
-
University of ManitobaCompleted
Clinical Trials on Soy
-
Abbott NutritionCompletedInfant, NewbornUnited States
-
John SievenpiperNot yet recruitingDyslipidemias | Cardiovascular Risk Factor | DysglycemiaCanada
-
Cancer Research MalaysiaKarolinska Institutet; University of Nottingham Malaysia; Subang Jaya Medical...UnknownBreast Cancer | Mammographic DensityMalaysia
-
University of Massachusetts, BostonTufts University; University of Massachusetts, Worcester; Hallmark Health SystemCompleted
-
Ohio State UniversityCompleted
-
Baylor College of MedicineUniversity of Alabama at Birmingham; Texas A&M University; University of Georgia and other collaboratorsCompletedOsteoporosisUnited States
-
Guelph Food Research CentreUniversity of Guelph; Glycemic Index Laboratories, Inc; Canadian Centre for Agri-Food...CompletedCardiovascular Disease | Hypercholesterolemia | CRPCanada
-
University of Colorado, DenverDuPont Nutrition and HealthCompletedObesity | Overweight | Weight LossUnited States
-
American Lung Association Asthma Clinical Research...National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...Completed
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedProstate CancerUnited States